Revenue
2021
2022
2023
2024
2025
Lhyfe SA (LHYFE)
Price€1.99Cached quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €9.8M | €5.1M | €1.3M | €570,000 | €197,000 |
| Research & development | — | — | — | — | €380,000 |
| Operating expenses | €42.1M | €32.1M | €34.5M | €18.3M | — |
| Operating income | −€47.6M | −€29.0M | −€34.4M | −€19.2M | −€5.7M |
| Operating margin | −487.16% | −568.82% | −2,609.64% | −3,362.46% | −2,883.25% |
| EBITDA | −€40.2M | −€25.5M | −€31.1M | −€18.1M | −€5.4M |
| EBITDA margin | −411.81% | −499.53% | −2,359.83% | −3,175.79% | −2,750.76% |
| Net income | −€51.0M | −€29.2M | −€33.6M | −€25.8M | −€8.7M |
| Net profit margin | −521.57% | −572.37% | −2,547.99% | −4,529.65% | −4,428.43% |
| Basic EPSper basic share | -€1.06 | -€0.61 | -€0.70 | -€0.70 | -€0.45 |
| Diluted EPSper diluted share | — | -€0.61 | -€0.70 | -€0.70 | -€0.45 |